Early Detection Means Better Results – Nearly 600 Enrolled in I-ELCAP

The WellStar Cancer Research program has partnered with the International Early Lung Cancer Action Program (I-ELCAP), an investigational lung cancer research study which allows people at high risk for lung cancer an opportunity to be screened for early stage disease.

This investigational study uses a low-dose CT scan to detect very small irregularities in the lungs that may indicate lung cancer in its earliest stage. The scan takes less then 20 seconds to perform and doesn’t involve any injections.
Nearly 600 at-risk patients have already enrolled in I-ELCAP. Participants must be at least 40 years of age and fall into any one of the following categories:

• Smoker or have a prior smoking history.
• Second hand smoke exposure for a minimum of 10 years. 
• Occupational exposure to environmental cancer-causing substances including chemicals, gases and inhaled dust particles.  

For more information about this investigational study, call 770-956-STAR.